State Street SPDR S&P Pha... (XPH)
NYSEArca: XPH
· Real-Time Price · USD
72.80
+0.51 (0.71%)
At close: Aug 21, 2026, 3:59 PM
73.54
+1.02%
After-hours: 7:37 PM
State Street SPDR S&P Pharmaceuticals ETF (XPH) ETF Price, Holdings & Analysis
0.71% (1D)
| Bid | 72.2 |
| Market Cap | n/a |
| AUM | 489.39M |
| NAV | 72.82 |
| Beta | 0.7 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 19.25 |
| Shares Out | 5.5M |
| Inception Date | Jun 19, 2006 |
| Ask | 73.61 |
| Volume | 83,598 |
| Avg. Volume (20D) | 100,387 |
| Open | 72.84 |
| Previous Close | 72.29 |
| Day's Range | 72.68 - 73.35 |
| 52-Week Range | 45.80 - 74.35 |
| Holdings | n/a |
| Expense Ratio | 0.35% |
About XPH
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Asset Class Equity
Ticker Symbol XPH
Inception Date Jun 19, 2006
Provider State Street Investment Management
Website Fund Home Page
Exchange NYSEArca
Top 10 Holdings 25.66% of assets
| Name | Symbol | Weight |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 3.69% |
| Mbx Biosciences Inc | MBX | 3.22% |
| Ataibeckley Inc | ATAI | 2.88% |
| Definium Therapeutic... | DFTX | 2.84% |
| Amylyx Pharmaceutica... | AMLX | 2.29% |
| Enliven Therapeutics... | ELVN | 2.24% |
| Corcept Therapeutics... | CORT | 2.22% |
| Alumis Inc | ALMS | 2.13% |
| Nuvation Bio Inc Ord... | NUVB | 2.09% |
| Trevi Therapeutics I... | TRVI | 2.06% |
Dividends Dividend Yield 0.46%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 22, 2026 | $0.0590 | n/a |
| Mar 23, 2026 | $0.0610 | n/a |
| Dec 22, 2025 | $0.1130 | n/a |
| Sep 22, 2025 | $0.1030 | n/a |
| Jun 23, 2025 | $0.0960 | n/a |
Page 1 of 2